Investor Presentaiton
Top-tier talent
Differentiated process
Our ambitious vision for Strategy & Analytics
•
Strategic search and evaluation
Development
landscape scanning
a
NIN
Therapeutic area
mapping
Monitoring
Clinical trial meta-
emerging science analysis and design
Medical claims
analysis
Scalable platform
Data and analytics
!!!!!
Real world Sales & marketing Payor & formulary
evidence
benchmarking
landscape
Horizon scanning to position Royalty Pharma for the future
Identify emerging target companies and products
Enhance knowledge of pipelines and mechanisms in development
Perform clinical trial analysis and competitive intelligence
Stay ahead of faster biopharma innovation cycles
Earlier partner engagement benefits business development
Unique insight from proprietary integration of data sources
Automation to ensure full coverage at scale
Best-in-class platform for market evaluation and forecasting
Patient mapping - diagnosis, procedures and treatment
Long-term ambition to develop for global markets
Strategy & Analytics improves Royalty Pharma's investment process and adds value to our partners
ROYALTY PHARMA
58View entire presentation